Business Description
InnoCan Pharma Corp
NAICS : 325412
SIC : 3741
ISIN : CA45783P1027
Share Class Description:
FRA:IP4: Ordinary SharesCompare
Compare
Traded in other countries / regions
INNO.CanadaIP4.GermanyINNPF.USA IPO Date
2020-03-31Description
InnoCan Pharma Corp is a pharmaceutical tech company that focuses on the development of several drug delivery platforms combining cannabidiol with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals. Geographically, it derives a majority of its revenue from the United States.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 6850 | |||||
| Equity-to-Asset | 0.54 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 9.94 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 35.4 | |||||
| 3-Year EPS without NRI Growth Rate | 15.1 | |||||
| 3-Year FCF Growth Rate | 10.2 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 54.77 | |||||
| 9-Day RSI | 53.81 | |||||
| 14-Day RSI | 52.45 | |||||
| 6-1 Month Momentum % | -25.5 | |||||
| 12-1 Month Momentum % | -35.22 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.57 | |||||
| Quick Ratio | 2.28 | |||||
| Cash Ratio | 1.91 | |||||
| Days Inventory | 309.22 | |||||
| Days Sales Outstanding | 0.22 | |||||
| Days Payable | 36.87 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -12.5 | |||||
| Shareholder Yield % | -3.24 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 90.12 | |||||
| Operating Margin % | -4.16 | |||||
| Net Margin % | -8.94 | |||||
| FCF Margin % | -8.24 | |||||
| ROE % | -57.54 | |||||
| ROA % | -31.44 | |||||
| ROIC % | 121.54 | |||||
| ROC (Joel Greenblatt) % | -132.52 | |||||
| ROCE % | -10.33 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.62 | |||||
| PB Ratio | 9.58 | |||||
| Price-to-Tangible-Book | 15 | |||||
| EV-to-EBIT | -78.95 | |||||
| EV-to-EBITDA | -84.62 | |||||
| EV-to-Revenue | 1.5 | |||||
| EV-to-FCF | -18.22 | |||||
| Price-to-Net-Current-Asset-Value | 15 | |||||
| Earnings Yield (Greenblatt) % | -1.27 | |||||
| FCF Yield % | -4.91 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
InnoCan Pharma Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 26.514 | ||
| EPS (TTM) (€) | -0.008 | ||
| Beta | 0.06 | ||
| Volatility % | 32.45 | ||
| 14-Day RSI | 52.45 | ||
| 14-Day ATR (€) | 0.008015 | ||
| 20-Day SMA (€) | 0.1456 | ||
| 12-1 Month Momentum % | -35.22 | ||
| 52-Week Range (€) | 0.1315 - 0.2845 | ||
| Shares Outstanding (Mil) | 286.94 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
InnoCan Pharma Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
InnoCan Pharma Corp Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
InnoCan Pharma Corp Frequently Asked Questions
What is InnoCan Pharma Corp(FRA:IP4)'s stock price today?
The current price of FRA:IP4 is €0.15. The 52 week high of FRA:IP4 is €0.28 and 52 week low is €0.13.
When is next earnings date of InnoCan Pharma Corp(FRA:IP4)?
The next earnings date of InnoCan Pharma Corp(FRA:IP4) is .
Does InnoCan Pharma Corp(FRA:IP4) pay dividends? If so, how much?
InnoCan Pharma Corp(FRA:IP4) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers